-
Product Insights
Spinal Cord Injury – Drugs In Development, 2023
Global Markets Direct’s, ‘Spinal Cord Injury - Drugs In Development, 2023’, provides an overview of the Spinal Cord Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Spinal Cord Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Spinal Cord Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Spinal cord injury (SCI) is defined as damage or trauma caused to the spinal cord. SCI can lead to loss or impaired function resulting in reduced mobility or feeling. It is usually caused by trauma, transverse myelitis, polio, spina bifida, or Friedreich's ataxia. Signs and symptoms of spinal cord injury include extreme back pain or pressure in the neck, head, or back, paralysis in any part of the body, numbness, tingling or loss of sensation in the hands, fingers, feet,...
-
Product Insights
Spinal Cord Injury Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Spinal Cord Injury Global Clinical Trials Review, H2, 2018" provides an overview of Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Spinal Cord Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2018" provides an overview of Acute Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Spinal Cord Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2017" provides an overview of Acute Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Spinal Cord Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2016" provides an overview of Acute Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Spinal Cord Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Spinal Cord Injury Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Spinal Cord Injury Global Clinical Trials Review, H2, 2016" provides an overview of Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Spinal Cord Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...